Financials data is unavailable for this security.
View more
Year on year SpectraCure AB (publ) has grown net income from a loss of -25.38m to a smaller loss of -20.44m despite declining revenues.
Gross margin | 442.39% |
---|---|
Net profit margin | -895.85% |
Operating margin | -917.34% |
Return on assets | -14.82% |
---|---|
Return on equity | -16.50% |
Return on investment | -15.91% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at SpectraCure AB (publ) fell by 36.23m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 18.68m for operations while cash used for investing totalled 15.56m.
Cash flow per share | -0.1914 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.21 |
---|---|
Tangible book value per share | 0.3238 |
More ▼
Balance sheet in SEKView more
Current ratio | 3.74 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0519 |
---|---|
Total debt/total capital | 0.0494 |
More ▼